Cytosorbents (CTSO)

P/S ratio as of November 2026 (TTM): 0.4064

According to Cytosorbents's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -20.1. At the end of 2023 the company had a P/S ratio of 1.86.

P/S ratio history for Cytosorbents from 2009 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	1.86	-19.13%
2022	2.30	-49.28%
2021	4.54	-47.98%
2020	8.73	58.3%
2019	5.52	-56.49%
2018	12.7	-9.04%
2017	13.9	-17.61%
2016	16.9	-51.5%
2015	34.9	-52.7%
2014	73.7	92.9%
2013	38.2
2012	N/A	-100%
2011	787
2010	N/A
2009	N/A

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Boston Scientific BSX	3.01	639.59%	🇺🇸 USA
Hologic HOLX	4.11	911.80%	🇺🇸 USA
Meridian Bioscience VIVO.defunct	4.47	1,000.03%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Cytosorbents (CTSO)

P/S ratio as of November 2026 (TTM): 0.4064